Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Falanga

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Blood|December 9, 2000
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia veraA Falanga, M Marchetti, V Evangelista, et al.
British Journal of Haematology|December 1, 1993
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgeryA Falanga, F A Ofosu, S Cortelazzo, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Nanotechnology|September 26, 2015
Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicityD Guarnieri, O Muscetti, A Falanga, et al.
Thrombosis and Haemostasis|August 13, 1990
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activityM B Donati, A Falanga, R Consonni, et al.
Thrombosis Research|May 11, 2016
PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN)C Giaccherini, C Verzeroli, M Marchetti, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Autoimmunity|October 25, 2006
Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndromeA M Marmont, F Gualandi, D Occhini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trialM Mandalà, S Barni, M Prins, et al.
Journal of Thrombosis and Haemostasis : JTH|May 14, 2004
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trialA Piccioli, A W A Lensing, M H Prins, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood|December 9, 2000
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia veraA Falanga, M Marchetti, V Evangelista, et al.
British Journal of Haematology|December 1, 1993
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgeryA Falanga, F A Ofosu, S Cortelazzo, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Nanotechnology|September 26, 2015
Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicityD Guarnieri, O Muscetti, A Falanga, et al.
Thrombosis and Haemostasis|August 13, 1990
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activityM B Donati, A Falanga, R Consonni, et al.
Thrombosis Research|May 11, 2016
PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN)C Giaccherini, C Verzeroli, M Marchetti, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Autoimmunity|October 25, 2006
Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndromeA M Marmont, F Gualandi, D Occhini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trialM Mandalà, S Barni, M Prins, et al.
Journal of Thrombosis and Haemostasis : JTH|May 14, 2004
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trialA Piccioli, A W A Lensing, M H Prins, et al.
Pageof 9